Literature DB >> 6689173

Bacterial immunostimulant (Broncho-Vaxom) versus levamisole on the humoral immune response in mice.

A Bosch, F Lucena, R Parés, J Jofre.   

Abstract

A comparative study on the enhancement of humoral immune response in mice after oral treatment with levamisole or a lyophilized bacterial lysate (Broncho-Vaxom) is presented. The latter proves to be more effective at therapeutic doses than levamisole on the induction of immunoglobulin formation and particularly that of IgA in secretions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6689173     DOI: 10.3109/08923978309026446

Source DB:  PubMed          Journal:  J Immunopharmacol        ISSN: 0163-0571


  3 in total

1.  Immunomodulation with bacterial extracts in respiratory diseases.

Authors:  A G Palma-Carlos; M L Palma-Carlos
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Broncho-Vaxom inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187.

Authors:  A Németh; P Magyar
Journal:  Agents Actions       Date:  1989-04

3.  Inhibition of spontaneous pulmonary metastases of Lewis lung carcinoma by oral treatment with Respivax and Broncho-Vaxom.

Authors:  K T Kassabov; J N Stoychkov
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.